Dataset Information


Therapy-Induced Developmental Reprogramming of Prostate Cancer Cells and Acquired Resistance [Dataset 1]

ABSTRACT: Treatment-induced neuroendocrine transdifferentiation (NEtD) complicates therapies for metastatic prostate cancer (PCa). We propose that NEtD requires first an intermediary reprogramming to metastable cancer stem-like cells (CSCs) and showed that AR+/PSA+ PCa cell lines were efficiently reprogrammed to and maintained as CSCs by growth in androgen-free neural/neural crest (N/NC) stem medium. Such reprogrammed CSCs overexpressed stem genes, had features of N/NC stem cells, high tumor-initiating potential, resistance to anti-androgen and an EMT phenotype. Serum-containing mediums allowed re-differentiation to N-/NC-derived cell lineages or return back to PCa-like cancer cells. Once returned, the cells had increased resistance to androgen signaling inhibition. Finally, a 62-gene signature derived from reprogrammed PCa cell lines distinguished tumors from PCa patients with adverse outcomes. To compare gene expression between parental PCa cells and STM-reprogrammed cells (LNCaP, VCaP, CWR-22rv1 and LAPC4), RNAs from biological triplicate samples of parental cells and corresponding STM-reprogrammed cells (>14 days in STM) were extracted.

ORGANISM(S): Homo sapiens  

SUBMITTER: Josselin Caradec   Amy A Lubik  Ralph Buttyan  Shawn Anderson  Mannan Nouri 

PROVIDER: E-GEOD-66850 | ArrayExpress | 2016-03-11



Similar Datasets

2016-03-11 | E-GEOD-66851 | ArrayExpress
2009-11-24 | GSE19141 | GEO
2009-11-28 | E-GEOD-19141 | ArrayExpress
2016-02-06 | E-GEOD-77613 | ArrayExpress
| GSE77379 | GEO
2016-02-06 | E-GEOD-77614 | ArrayExpress
2016-02-06 | E-GEOD-77612 | ArrayExpress
2015-06-23 | E-GEOD-21612 | ExpressionAtlas
2010-07-30 | E-GEOD-21612 | ArrayExpress
2010-07-01 | GSE21612 | GEO